BioPure Healing Products, LLC v. WellNX Life Sciences, Inc
Filing
73
ORDER DIRECTING PLAINTIFF TO POST A $75,000 SECURITY BOND WITH THE COURT by Hon. James P. Donohue. (AE)
1
2
3
4
5
6
UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF WASHINGTON
AT SEATTLE
7
8
9
10
11
12
NO. C17-470-RSL
BIOPURE HEALING PRODUCTS, LLC,
Plaintiff,
v.
WELLNX LIFE SCIENCES, INC. and
PLATINUM US DISTRIBUTION, INC. d/b/a
WELLNX LIFE SCIENCES, USA,
13
ORDER DIRECTING PLAINTIFF
TO POST A $75,000 SECURITY
BOND WITH THE COURT
Defendants.
14
15
16
I.
INTRODUCTION
This matter comes before the Court upon the parties’ numerous submissions regarding
17
an appropriate injunction bond amount under Fed. R. Civ. P. 65(c). Dkts. 60-66, 69-70.1 On
18
August 24, 2017, the Honorable Robert S. Lasnik granted plaintiff’s motion for preliminary
19
injunction, which becomes effective on September 23, 2017. Dkt. 58. To date, the parties
20
have been unable to reach an agreement as to the appropriate bond amount in this case.
21
Having reviewed the parties’ briefs and supporting materials, the governing law, and the
22
23
24
1
The parties were previously directed by the Court to either submit a stipulation as to
the amount of the bond, or if they are unable to agree, submit separate submissions explaining
their respective positions. Dkt. 49 at 29.
ORDER - 1
1
balance of the record, the Court exercises its discretion under Rule 65(c) to set a bond in the
2
amount of $75,000.
II.
3
DISCUSSION
4
A. Legal Standard
5
Federal Rule of Civil Procedure 65(c) provides that this “court may issue a preliminary
6
injunction . . . only if the movant gives security in an amount that the court considers proper to
7
pay the costs and damages sustained by any party found to have been wrongfully enjoined for
8
restrained.” Fed. R. Civ. P. 65(c). The Ninth Circuit has recognized that Rule 65(c) “invests
9
the district court with discretion as to the amount of security required, if any.” Johnson v.
10
Couturier, 572 F.3d 1067, 1086 (9th Cir. 2009) (internal quotations omitted). The district
11
court may therefore “dispense with the filing of a bond when it concludes that there is no
12
realistic likelihood of harm to the defendant from enjoining his or her conduct.” Id.
13
The burden of providing that a bond is needed is on the party requesting the bond. See
14
Conn. Gen. Life Ins. Co. v. New Images of Beverly Hills, 321 F.3d 878, 883 (9th Cir. 2003).
15
The moving party’s size and financial resources may also be considered in setting a reduced
16
bond amount. See GoTo.com, Inc. v. Walt Disney Co., 202 F.3d 1199, 1211 (9th Cir. 2000)
17
(district court did not abuse discretion by requiring a $25,000 bond and defendants request to
18
significantly raise that amount “would risk denying [the plaintiff] access to judicial review
19
since the preliminary injunction would not take effect until [the plaintiff] posted the bond.”);
20
Color Me House, Inc. v. Discovery Commc’ns, Inc., Case No. C12-5935-RJB, 2013 WL
21
1283806, *10 (March 27, 2013) (holding that a $1,000 minimal bond is all that is required
22
because plaintiff “has shown a strong likelihood of success on the merits, it is a small business,
23
and it does not have the resources to purchase a large bond.”).
24
ORDER - 2
1
B. Parties’ Contentions
2
Defendants ask the Court to require BioPure to post a bond in the amount of $474,400.
3
Dkt. 60. Defendants argue that the evidence they have provided from third-party data (along
4
with defendants’ own price lists) demonstrate that $474,400 is the “actual, out-of-pocket costs”
5
that defendants will incur in order to comply with the preliminary injunction issued by the
6
Court. Dkt. 65 at 2. WellNX estimates its costs of complying with the preliminary injunction
7
as follows: (1) costs of existing bottles, labels, and packages bearing the name “BioPure” that
8
must be destroyed ($86,000); (2) costs of new bottles, labels and packages that do not bear the
9
name “BioPure” ($86,000); (3) labor costs to un-package and repackage the inventory
10
($182,000); (4) third-party vendor overage charges ($70,400); and (5) costs of excess labels,
11
bottles, and packaging (i.e. inventory) bearing the name “BioPure” that were to be used to
12
package and label products, but now must be destroyed ($50,000). Dkt. 60 at 3.
13
Specifically, WellNX asserts that it needs to repackage approximately 200,000 units of
14
products bearing the “BioPure” name on the bottle, label, or packaging, which will require
15
buying new bottles, new labels, and new boxes for a total of $86,000. Dkt. 61 (First Johnson
16
Decl.) at ¶¶ 3-4.2 WellNX asserts that because it will not only need to purchase new packaging
17
but destroy the old packaging, which it had already purchased at $0.43 per unit, the loss of that
18
old packaging is an additional $86,000. Id. See also Dkt. 61, Ex A (WellNX’s price sheet,
19
reflecting the bottle, label, and box costs). Thus, defendants assert that the “hard costs” of
20
repacking, before labor, equal $172,000. WellNX will utilize its third party fulfillment center
21
Dynamics, Inc. for the labor of the repacking effort, at a cost of $0.91 per unit, for a total of
22
23
24
2
WellNX’s actual cost for the bottles is $0.185 per bottle, $.035 for labels, and $0.21
for boxes. Thus, WellNX asserts that the hard costs of the new packaging will cost $0.43 per
unit, or a total of $86,000. Id. at ¶ 4.
ORDER - 3
1
$182,000 in labor costs. Dkt. 61 (First Johnson Decl.) at ¶ 5. See also Dkt. 61, Ex. B
2
(Dynamics’ estimate of labor costs, totaling $0.91 per unit). In addition, WellNX asserts that
3
“third party vendors typically estimate a potential overage charge equaling 20% of the total
4
cost,” which defendants assert is $70,400. Finally, WellNX has approximately $50,000 of
5
packaging inventory on hand that now must be destroyed. In total, WellNX estimates its out-
6
of-pocket expenses associated with complying with the injunction to be $474,400 ($86,000 +
7
$86,000 + $182,000 + $70,400 + $50,000), and seeks a bond in that amount. Dkt. 61 (First
8
Johnson Decl.) at ¶ 8.
9
By contrast, BioPure contends that a $45,000 bond sufficiently protects defendants’
10
interests, and more appropriately takes into account the small size and limited financial
11
resources of BioPure. Dkt. 62 at 12. Specifically, BioPure explains that despite the Court’s
12
Order that the parties meet and confer to discuss an appropriate bond amount, prior to filing
13
their separate submission with the Court, defendants never provided plaintiff with any
14
documentation supporting their requested figures, which initially totaled $850,000 during the
15
parties’ meet and confer telephone conference on August 29, 2017. Dkt. 64 (Levy Decl.) at ¶¶
16
5-7. Although defendants significantly reduced their requested bond by the time of the parties’
17
second meet and confer telephone conference on September 7, 2017, defendants never
18
provided BioPure with documentation to support either of their proposed bond amounts. Dkt.
19
62 at 5. See also Dkt. 64 (Levy Decl.) at ¶¶ 16-20. Thus, BioPure contends that defendants’
20
conduct during their two meet and confer telephone conferences prevented the parties from
21
making any real progress towards reaching an agreement on the bond amount.
22
With respect to WellNX’s $474,400 bond request, BioPure argues that WellNX has
23
greatly inflated its estimated costs to prevent BioPure from receiving the benefit of the
24
injunctive relief the Court has ordered. For example, BioPure contends that defendants’ unit
ORDER - 4
1
costs for packaging have been improperly doubled to account for new, non-infringing
2
packaging, as well as the costs of destroying existing packaging. BioPure points out that
3
WellNX would have to pay for one set of packaging regardless of the injunction, and the cost
4
of complying with the injunction should therefore only include the additional repackaging
5
costs. Id. at 7. Similarly, BioPure contends that “the alleged $50,000 cost for excess labels in
6
Wellnx’s inventory is not damage caused by the injunction because the injunction does not
7
require destruction of the labels. They can be stored and used later if the preliminary
8
injunction were reversed on appeal.” Dkt. 69 at 2. In addition, BioPure asserts that WellNX’s
9
vague and speculative $70,400 charge for “potential” penalties charged by retailers for late
10
shipments should be disregarded, as WellNX has been on notice since the July 6, 2017 date of
11
the Report and Recommendation that it would need to alter its packaging to meet its shipment
12
commitments and provides no evidence supporting this “potential overage charge.” Dkt. 69 at
13
5; Dkt. 63 (Annicchiarico Decl.) at ¶¶ 20-22.
14
Finally, BioPure points out that WellNX’s estimate for both the hard costs and labor
15
required to repack its 200,000 units of inventory was based only on defendants’ Slimquick
16
Pure pills, which require a carton, bottle, and a label (and are therefore the most expensive to
17
repack) when there are actually three different types of enjoined products with different
18
packaging needs. Dkt. 69 at 6.3 BioPure’s CEO Mr. Annicchiarico, relying on his own
19
experience and the material costs provided by WellNX, estimates that it would cost only
20
21
22
23
24
3
With respect to the pills, BioPure argues that WellNX’s estimated labor charge of
$0.91 per unit is an “absurdly high figure” that is “more than twenty times the going rate for
this type of work.” Dkt. 62 at 11. BioPure contends that WellNX was only required by the
preliminary injunction to place new labels over the top of the existing labels, and therefore the
“material costs for a new bottle and new cap are not required to comply with the injunction.
The bottles themselves do not display the BIOPURE name, only the labels placed on them.”
Dkt. 62 at 11.
ORDER - 5
1
$45,000 ($33,000 for materials and $12,000 for labor) for several temporary employees to
2
repackage the enjoined products by simply placing new labels over the old labels. Dkt. 63
3
(Annicchiarico Decl.) at ¶¶ 18-20. Alternatively, if new bottles and caps must be used,
4
BioPure contends that “it would surely be less expensive to limit the manual labor to the
5
emptying of the packages,” and “once the product was removed, Wellnx could use its existing
6
automated processes to package and label the product.” Dkt. 69 at 7. Again, Mr.
7
Annicchiarico estimates that the cost of such labor would equal no more than $12,000. Dkt. 70
8
(Second Annicchiarico Decl.) at ¶ 70.
9
Defendants respond that Mr. Annicchiarico is merely speculating, as he has no
10
experience in the repacking of consumer products to be distributed in mass retail outlets and he
11
does not cite to any third-party data to support his conclusions. Dkt. 65 at 3-4. Defendants
12
assert that Mr. Annicchiarico’s suggestions for repacking the products less expensively (such
13
as simply placing a new sticker over the old sticker that contained the word “BioPure”) are not
14
workable for a variety of reasons and would negatively impact defendants’ brand and its
15
relationship with its retail partners and consumers. Id. For example, Dana Johnson, President
16
of WellNX Life Sciences, Inc., asserts that in the past “WellNX has done a repack by simply
17
placing a new sticker over the old sticker. When we did that, we experienced significant
18
consumer backlash, with consumers complaining, among other things, that the product
19
appeared to be ‘tampered with’ and that the product was different than that reflected in the new
20
label.” Dkt. 66 (Second Johnson Decl.) at ¶ 5. Ms. Johnson asserts that the “the result was a
21
significant decline in sales, as well as harm to the perception of our product with the
22
consumers and our mass retail partners. As a result, other repacks that we have done since that
23
time have all followed the same procedure as we are going here – new bottles, new labels and
24
new boxes, all re-packed by a third party professional organization.” Id. Defendants further
ORDER - 6
1
contend that they have worked with these same professional companies before and “it is
2
industry standard that such repacks are done by professional, third party companies, in
3
professional FDA-approved facilities, especially since these are products that are sold in mass
4
retail outlets throughout the country.” Id. at ¶ 6.4
5
C. The Court Finds that a $75,000 Bond is Sufficient in this Case
6
As a threshold matter, the Court observes that although WellNX technically complied
7
with the Court’s meet and confer requirement by participating in two telephone conferences
8
with counsel for BioPure, WellNX’s failure to submit any documentation in support of its bond
9
estimates to BioPure prevented the parties from reaching an agreement. See Dkt. 64 (Levy
10
Decl.) at ¶¶ 5-7, 16-20. Based upon WellNX’s submissions to the Court in support of its
11
current bond request of $474,400, it is difficult to fathom how WellNX’s initial $850,000
12
estimate could have had any basis in fact and have been made in good faith. As discussed
13
below, given the dearth of documentation submitted to the Court by WellNX to support its
14
current request for a $474,400 bond, the Court finds that a $75,000 bond is sufficient in this
15
case.
16
Costs for defendants’ existing bottles, labels, and packages that bear the BioPure name,
17
and therefore can no longer be used by WellNX following September 23, 2017, are
18
appropriately included in the bond estimate. As noted above, however, the documentation
19
provided by WellNX is insufficient for the Court to substantiate the $86,000 amount sought by
20
WellNX for this existing packaging. See Dkt. 61, Exs. A-B. As BioPure points out, WellNX’s
21
packaging needs differ product by product, and only one of the three products bearing the
22
4
23
24
Defendants assert that the $0.91 labor costs are not exorbitant and are consistent with
the work to be performed on this significant repack, and consistent with the charges that
WellNX has paid in prior repacks. Id. at ¶ 7. Defendants further assert that the cost to
produce the fully furnished product are significantly greater than $0.91 per unit. Id.
ORDER - 7
1
“BioPure” name will require replacement of a bottle, label, and carton.5 WellNX’s $86,000
2
estimate presumes that all 200,000 units require all this packaging, when this is not the case.
3
See Dkt. 63 (Annicchiarico Decl.) at ¶¶ 12-16. Although WellNX concedes that the three
4
products in its inventory requiring repacking include “132,851 units pills/powder, 53,401 of
5
Mixed Berries, and, 16,290 Gummies,” WellNX does not provide an explanation of its actual
6
packaging needs for each of these products. See Dkt. 66 (Second Johnson Decl.) at ¶ 9.6 The
7
Court finds that WellNX’s $86,000 amount significantly overestimates the costs of the existing
8
bottles, labels, and packages bearing the name “BioPure.”
9
Similarly, just as WellNX has not adequately explained what packaging is needed to
10
repack the three distinct products at issue, the Court cannot determine from WellNX’s
11
submissions what labor is actually needed to complete the repack of all three products.
12
WellNX’s estimate from Dynamics, Inc. for $0.91 per unit only pertains to a product that
13
requires a new bottle, label, and carton. Dkt. 61, Ex. 2. However, WellNX does not dispute
14
BioPure’s evidence that all of these steps will not be required to repack all three products. Dkt.
15
63 (Annicchiarico Decl.) at ¶¶ 12-16. For example, the powder drink mix will only require a
16
new paper carton, as the word “BioPure” does not appear on the individual powder packets.
17
Dkt. 63 (Annicchiarico Decl.) at ¶¶ 14-15. As a result, WellNX’s $182,000 estimate for labor
18
(200,000 units times $.091 per unit = $182,000) is inaccurate. As discussed above, WellNX
19
has the burden of establishing what costs would be incurred by the company in complying with
20
5
21
22
23
24
Although the parties disagree regarding whether a new bottle is necessary to repack
the supplements and gummies, the Court finds that WellNX has provided sufficient evidence to
explain why a new bottle is needed.
6
WellNX’s reference to “53,401 Mixed Berries” may refer to the mixed berries
flavored drink mix, which would only require a new paper carton and no new bottle or other
label. Dkt. 63 (Annicchiarico Decl.) at ¶ 14. However, this powdered drink mix, which would
require minimal packaging and labor, may also be included in WellNX’s estimated “132,851
units pills/powder.”
ORDER - 8
1
the preliminary injunction in this case. Based upon the evidence submitted by both parties, the
2
Court finds that $75,000 is a reasonable estimate to encompass both the costs of the existing
3
bottles, labels, and packages bearing the name “BioPure” and the labor needed to complete the
4
repack of these products.
5
The Court exercises its discretion not to include the additional sums requested by
6
defendants in the bond amount, such as the costs of excess labels, bottles, and packaging (i.e.
7
inventory) bearing the BioPure name that were intended to be used to package and label
8
defendants’ products in the future. As noted above, WellNX received notice of the preliminary
9
injunction over two months ago on the date of the July 6, 2017 Report and Recommendation,
10
which specifically stated that the injunction would “take effect thirty (30) days” after Judge
11
Lasnik’s adoption of the R&R “in order to provide defendant with sufficient time to alter its
12
packaging.” Dkt. 49 at 28. However, WellNX has not described any effort on its part to either
13
liquidate or use up its non-conforming inventory prior to September 23, 2017. The Court has
14
provided WellNX with ample time to implement measures to minimize the costs and expenses
15
associated with compliance, including using up existing inventory. As far as the Court is
16
aware, based on WellNX’s own submissions to the Court, no such efforts were made.7 As a
17
result, the $50,000 of excess packaging inventory shall not be included the bond estimate.
18
With respect to WellNX’s request for an additional $86,000 to cover the expense of
19
new bottles, labels and packages that comply with the injunction, the Court agrees with
20
BioPure that the cost of new packaging would have been incurred in the ordinary course of
21
WellNX’s business to sell its products. If the cost of the existing packaging and new
22
23
24
7
If substantial efforts have been made by WellNX to reduce costs and prepare for the
September 23, 2017 deadline, WellNX chose not to describe them to the Court and instead, to
seek a high bond amount.
ORDER - 9
1
packaging for the 200,000 units were both included in the bond estimate, it would amount to
2
double-recovery for WellNX. In addition, WellNX has provided no evidence that it will be
3
charged third-party vendor overage charges ($70,400). Without more, Ms. Johnson’s
4
statement that “in any major relabeling/repackaging situation . . . third party vendors typically
5
estimate a potential overage charge equalizing 20% of the total cost” does not establish that
6
WellNX will actually incur any such charges in this case, particularly if WellNX took
7
reasonable steps during the last two months to prepare for the repack. Dkt. 61 (Johnson Decl.)
8
at ¶ 6. Accordingly, the costs of new packaging and the speculative third-party vendor overage
9
charges are not included in the bond.
10
Finally, the Court notes that both parties in this case have expressed concerns regarding
11
the high costs of this litigation, and the limited financial resources of their relatively small
12
companies. See Dkt. 62 at 12 (“BioPure is a small closely held company with limited financial
13
resources. A very large bond amount . . . may prevent BioPure from being able to receive the
14
relief that the Court has ordered.”); Dkt. 66 (Second Johnson Decl.) at ¶ 3 (“[T]he costs of
15
properly complying with the preliminary injunction . . . will take a significantly financial toll
16
on Wellnx” and “will likely result in the reduction of at least 1 of our 15 employees, and put
17
the company on the verge of insolvency.”). The primary issue driving this case has been
18
decided, at least preliminarily. The parties should be able to reach a resolution at this stage, if
19
they are serious about reducing the impact of litigation costs on their operations. Accordingly,
20
the Court directs the parties to meet and confer within two weeks from the date of this Order
21
regarding the possibility of early mediation, and promptly advise the Court as to the outcome
22
of those discussions.
23
24
ORDER - 10
III.
1
2
CONCLUSION
For the reasons discussed above, the Court directs the plaintiff to post a bond in the
3
amount of $75,000 to pay the costs and damages sustained by defendants, if they are later
4
found to have been wrongfully enjoined. BioPure shall secure and register the bond with the
5
Court within two weeks of the date of this Order. The Clerk is directed to send a copy of this
6
Order to counsel for both parties and to Judge Lasnik.
7
DATED this 20th day of September, 2017.
8
A
9
10
JAMES P. DONOHUE
Chief United States Magistrate Judge
11
12
13
14
15
16
17
18
19
20
21
22
23
24
ORDER - 11
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?